Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Ovarian Cancer 101: Breakout session for recently diagnosed ovarian cancer patients
Ovarian Cancer 101: Breakout session for recently diagnosed ovarian cancer patients
by morgan
Christopher Morse, MD. Fellow, Gynecologic oncolog...
Five Years Single Institution Retrospective Analysis of the Borderline Ovarian Tumors
Five Years Single Institution Retrospective Analysis of the Borderline Ovarian Tumors
by wilson
Ghanim. . Khatib. , . Ümran . Küçükgöz. . G...
Ovarian Cancer
Ovarian Cancer
by natalia-silvester
Ovarian Cancer. Epithelial Tumor, . postmenopausa...
Single centre experience of ovarian adult
Single centre experience of ovarian adult
by payton
granulosa. cell . tumours. Jo Moffatt ST4. Claire...
Ovarian Cancer * Globally 7
Ovarian Cancer * Globally 7
by southan
th. most incident and lethal cancer. New cases: 2...
IN THE NAME OF GOD The effect of vasopressin injection on ovarian reserve in laparoscopic cystect
IN THE NAME OF GOD The effect of vasopressin injection on ovarian reserve in laparoscopic cystect
by blackwidownissan
;. a . clinical trial. Dr s.Rouholamin. Dr f....
COMPARATIVE STUDY OF OVARIAN RESERVE BETWEEN THE USERS AND
COMPARATIVE STUDY OF OVARIAN RESERVE BETWEEN THE USERS AND
by mitsue-stanley
Abstract . id. : 1183. This . study aims . T...
Patient Selection for PARP
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
Michelle Boisen , MD Assistant professor of Gynecologic oncology
Michelle Boisen , MD Assistant professor of Gynecologic oncology
by calandra-battersby
Magee-. Womens. Hospital of UPMC. Clinical and R...
1. In general, when do you typically order mutation testing for your patients with newly diagnosed
1. In general, when do you typically order mutation testing for your patients with newly diagnosed
by opelogen
At initial diagnosis . 0. At first relapse . 0. At...
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay o
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay o
by genderadidas
 . Boris . Winterhoff. , MD, MS. 1,11,12. , . Ste...
by medshair
Five-year . survival. 15%. 30%. 40%. ?50%?. First ...
depends on stage histological type age presence of ascitesin patie
depends on stage histological type age presence of ascitesin patie
by skylar
SUSANNE MARKMANN, BERND GERBER andVOLKER BRIESE Ne...
28 Million £ Down The Drain
28 Million £ Down The Drain
by briana-ranney
Muhieddine Seoud, MD, FACOG, FACS. American Unive...
Should you operate? Surgery in the fertility patient.
Should you operate? Surgery in the fertility patient.
by myesha-ticknor
Kevin Doody MD. Conflict of interest. Owner, admi...
Transforming treatment and improving survival for
Transforming treatment and improving survival for
by olivia-moreira
ovarian cancer patients. Laura Shawver, PhD. Foun...
Management of Women with
Management of Women with
by danika-pritchard
Clomiphene . Citrate. Resistant Polycystic Ovary ...
Case Discussion: Second
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome
by olivia-moreira
Role of Imaging in Diagnosis. DR . Seyed. . Asa...
Establishing an Evidence Based Cutoff: Basal Follicle Stimulating Hormone (FSH) Levels of 8 or Grea
Establishing an Evidence Based Cutoff: Basal Follicle Stimulating Hormone (FSH) Levels of 8 or Grea
by susan2
. Paige Persch, . M.D.. a. . ; Alexis . Visotcky....
The effect of genetic variation in
The effect of genetic variation in
by BabyDolly
unsuccessful. infertility treatment. N . Ghasemi. ...
Hereditary syndromes, genetic testing and
Hereditary syndromes, genetic testing and
by Kingslayer
gynaecological. cancers. Prof.. Nicoletta . Col...
Saint Marys Hospital
Saint Marys Hospital
by brooke
Ovarian CystsInformation For Patients 2 Welcome 4W...
British Gynaecological Cancer Society
British Gynaecological Cancer Society
by obrien
1 BGCS ) Epithelial Ovarian / Fallopian Tube / ...
NW regional audit of CA125 requesting in primary care
NW regional audit of CA125 requesting in primary care
by atharv578
NW Audit meeting format. Start of collaborative NW...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...
Journal club 2 Facilitator: Pawin
Journal club 2 Facilitator: Pawin
by lily
Puapornpong. A retrospective analysis of the effec...
Fertility Preservation in Breast Cancer
Fertility Preservation in Breast Cancer
by mia
Dr s.Hosseini. SBMU. Summer 2019. INTRODUCTION. Br...
Hysterectomy for Benign Disease
Hysterectomy for Benign Disease
by anastasia
Correspondence to: Dr Ting-Chung PunEmail: puntc@h...
Odunsi MD PhD
Odunsi MD PhD
by caitlin
Kunle Immunotherapy in Ovarian Cancer Kunle Oduns...
Polycystic ovarian syndrome insights into pathogenesis diagnosis pr
Polycystic ovarian syndrome insights into pathogenesis diagnosis pr
by patricia
7 Polycystic ovarian syndrome (PCOS) is one of the...
Anti Mullerian Hormones in Polycystic ovarian Syndrome Patients
Anti Mullerian Hormones in Polycystic ovarian Syndrome Patients
by stella
Moustafa Eissa MD FRCOG. Cyberjaya University Coll...
Value of Sequencing-Guided Treatment for Patients with
Value of Sequencing-Guided Treatment for Patients with
by calandra-battersby
Advanced Malignancies. METHODS. DISCUSSION. RESUL...
Anti Mullerian Hormones in Polycystic ovarian Syndrome Pati
Anti Mullerian Hormones in Polycystic ovarian Syndrome Pati
by sherrill-nordquist
Moustafa Eissa MD FRCOG. Cyberjaya University Col...
Pelvic Congestion Syndrome
Pelvic Congestion Syndrome
by phoebe-click
Treatment. S. . Lakhanpal . MD, FACS. President &...
The Nurse View: Clinical Considerations in the Management of
The Nurse View: Clinical Considerations in the Management of
by natalia-silvester
BRCA. -Mutated Advanced Ovarian Cancer. Moderator...
NEw developments IN gynecological Oncology
NEw developments IN gynecological Oncology
by cheryl-pisano
highlights from the. EUROPEAN . society . of med...
The Cultural Challenges in Cryopreservation for Cancer Patients in Sri
The Cultural Challenges in Cryopreservation for Cancer Patients in Sri
by brown
Nuha AnsarOxford University Global Surgery Unit Su...
British Journal of Cancer 1995 72 10161019 1995 Stockton Press All r
British Journal of Cancer 1995 72 10161019 1995 Stockton Press All r
by megan
1 V Levy2 G Rustin 3 T Perren4 AH Calvert5 H Earl6...
Peritoneal Nodules and Cytoreductive
Peritoneal Nodules and Cytoreductive
by Dragonfruit
Surgery. By . dr.Ahmed. . Samir. Surgical oncolog...